Matt Skelton is a seasoned biotech leader with extensive experience in driving global commercialization processes from development stages to successful launches. At Seagen, he scaled the commercial organization from a team of 9 to over 100, leading three successful product launches. His expertise spans global marketing, sales operations, market research, and forecasting, with a proven ability to lead cross-functional teams and develop strategic commercial plans. Prior to Seagen, Skelton held senior roles at Amgen, overseeing marketing and sales teams, and leading major product launches. He started his career at Eli Lilly as a sales representative. Skelton holds a B.A. from DePauw University.